Combination therapy in hypertension
Hypertension is one of the most important risk factors for death, heart failure, ischaemic heart disease, stroke and chronic kidney disease. Treatment of hypertension to particularly to goal blood pressure (BP) prevents these complications. In South Africa the reported control rates for treated hype...
Saved in:
| Main Author: | Brian Rayner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2007-03-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/776 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?
by: James A. Ker
Published: (2015-05-01) -
Comparative efficacy and predictive value of fixed combination of amlodipine and angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in patients with coronary heart disease, post-infarction cardiosclerosis and hypertension
by: M. M. Dolzhenko, et al.
Published: (2021-11-01) -
ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES
by: S. A. Shalnova, et al.
Published: (2015-12-01) -
Effects of combination antihypertensive therapy on intracardiac hemodynamics and blood vessels in patients with coronary heart disease, post-infarction cardiosclerosis and arterial hypertension
by: M. M. Dolzhenko, et al.
Published: (2023-07-01) -
Review: Investigation of the electrochemical properties of beta blockers and ACE inhibitors by cyclic voltammetry
by: Edhem Hasković, et al.
Published: (2020-06-01)